Arizona patient dies in emergency room from plague
The patient was recently treated at an emergency department in Flagstaff and died the same day, Northern Arizona Healthcare said.
Related Articles
Arizona patient dies in emergency room from plague
The patient was recently treated at an emergency department in Flagstaff and died the same day, Northern Arizona Healthcare said.
Fungal infections are getting harder to treat
The fungus Aspergillus fumigatus tops the World Health Organization’s list of worrying fungal diseases. It’s growing increasingly resistant to the first-line drug used to treat…
Medical students fret over the new student loan cap in the ‘big, beautiful bill’
The bill will cap total medical loans at $200,000 — far below the more than $300,000 median cost of attending medical school.
In deadly Texas floods, one town had what some didn’t: A wailing warning siren
Emergency officials are starting to focus on alert systems as they search for answers about how the flash flooding swept away so many.
Outside groups organize to form unbiased, independent vaccine panel
Since Robert F. Kennedy Jr. fired the members of the CDC’s esteemed vaccine advisory panel, medical organizations and experts are looking for alternatives.
Raw milk advocates wonder: Where is Kennedy?
Though the health and human services secretary has been avid fan of raw milk, he hasn’t pushed for changes to federal policies — yet.
Video shows hospital damaged by Israeli strike in western Iran
An Israeli airstrike targeted the Farabi hospital in the western Iranian city of Kermanshah, badly damaging its facilities, according to the Iranian Red Crescent. The…
This quick, but not so easy, test can predict how long you’ll live, study suggests
It’s a measure of balance, muscle strength and flexibility.
An injectable HIV-prevention drug is highly effective — but wildly expensive
Thrilled that lenacapavir, which is injected twice yearly, was highly effective in both gay men and women in clinical trials, HIV advocates worry it will…
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
